Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ELVR | SCZM |
|---|---|---|
| Price | $33.93 | $8.40 |
| Change today | ▼ 2.25% | ▼ 0.59% |
| Market cap | $654.92M | $781.12M |
| Return, 3 months | -46.7% | +25.9% |
| Return, year to date | -35.5% | -13.0% |
| Return, 1 year | +19.6% | +14.8% |
| P/E (TTM) | 12.6 | 18.7 |
| P/B | 0.9 | 3.7 |
| P/E percentile vs own 5y | 90th | 65th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +39.1% | +54.8% |
| Net profit growth (YoY) | +118.0% | -90.4% |
| Gross margin | 95.5% | 35.5% |
| Operating margin | 0.4% | 28.0% |
| Net margin | 21.4% | 10.0% |
| Return on equity | 8.6% | 22.5% |
| Analyst target vs. price | – | +102.0% |
| Analyst buy share | – | 100% |
| RSI (14) | 20 | 43 |
| 30-day volatility | 45.9% | 74.7% |
| Max drawdown, 1 year | -66.1% | -63.2% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
